Gladstone NOW: The Campaign Join Us on the Journey✕
Nearly half of all babies born with Down syndrome face congenital heart defects, often involving serious malformations that require surgery in the first months of life.
Using stem cells, gene editing, and AI, a team of scientists at Gladstone Institutes identified one gene that plays a key role in the heart defects seen in Down syndrome. Then, by reducing the levels of this gene in mice, they were able to fix the problem and restore normal heart development.
In this video, Deepak Srivastava, Katie Pollard, and Sanjeev Ranade explain what they found and how their work could pave the way for treatments to help prevent heart malformations in people with Down syndrome and related heart defects.
Read more about this study, which was published in the journal Nature.
Gladstone NOW: The Campaign
Join Us On The Journey
Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke
Article
July 1, 2026
Turning the Tide on Tau: Q&A With Gladstone’s Lennart Mucke
Nearly 20 years after his landmark study uncovered novel roles of tau in Alzheimer’s disease, Gladstone's Lennart Mucke shares his perspective on new clinical data that could transform the future of brain health.
Mucke Lab Alzheimer’s Disease Gladstone Experts Neurological Disease News ReleaseThis Is AI Decoding the Genetic Cause of Disease
Video
March 23, 2026
This Is AI Decoding the Genetic Cause of Disease
In this video, Katie Pollard and Deepak Srivastava explain how Gladstone scientists are combining AI models with novel tools in the lab to finally decode the entire human genome.
Gladstone Experts Pollard Lab Srivastava Lab AIScience in Seconds | A New Path Toward Life Without Daily HIV Pills
Video
March 20, 2026
Science in Seconds | A New Path Toward Life Without Daily HIV Pills
In this video, Nadia Roan and Ashley George explain how they uncovered a new path toward long-term health without the need for daily HIV pills.
Gladstone Experts Research (Publication) HIV/AIDS Infectious Disease Roan Lab